ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000262147.1	ABT-263 (navitoclax)	Bladder urothelial carcinoma	0.032979617	Sensitive
ENSG00000262147.1	ABT-263 (navitoclax)	Pancreatic adenocarcinoma	0.043353715	Sensitive